Literature DB >> 18657357

Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth.

Su Cheol Park1, Jung-Hwan Yoon, Jeong-Hoon Lee, Su Jong Yu, Sun Jung Myung, Won Kim, Geum-Youn Gwak, Sung-Hee Lee, Soo-Mi Lee, Ja June Jang, Kyung-Suk Suh, Hyo-Suk Lee.   

Abstract

Adrenomedullin is implicated in tumor progression and induced by hypoxia. We evaluated if adrenomedullin signaling is active in hepatocellular carcinoma (HCC), especially under hypoxic conditions, and to analyze its prognostic implication in HCC patients. HCC cells expressed adrenomedullin and its receptor, and hypoxia induced adrenomedullin expression. Adrenomedullin stimulated HCC cell growth via Akt activation, which was prevented by adrenomedullin peptide inhibitor. Clinico-pathological analysis revealed adrenomedullin extent was related to vascular invasion and N-cadherin intensity, which were reported to indicate a poor prognosis. In conclusion, adrenomedullin signaling is hypoxia-inducible and functionally active in HCCs, and its expression may be a prognostic factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657357     DOI: 10.1016/j.canlet.2008.06.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  RNA interference targeting adrenomedullin induces apoptosis and reduces the growth of human bladder urothelial cell carcinoma.

Authors:  Ai-guang Liu; Xi-zhong Zhang; Fen-bao Li; Yong-li Zhao; Ying-chang Guo; Rui-min Yang
Journal:  Med Oncol       Date:  2013-05-29       Impact factor: 3.064

2.  Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition.

Authors:  Chuang Zhou; Yan Zheng; Lin Li; Wenlong Zhai; Renfeng Li; Zhiwen Liang; Longshuan Zhao
Journal:  Oncol Rep       Date:  2015-06-05       Impact factor: 3.906

Review 3.  Adrenomedullin and tumour microenvironment.

Authors:  Ignacio M Larráyoz; Sonia Martínez-Herrero; Josune García-Sanmartín; Laura Ochoa-Callejero; Alfredo Martínez
Journal:  J Transl Med       Date:  2014-12-05       Impact factor: 5.531

4.  Overexpression of adrenomedullin protects mesenchymal stem cells against hypoxia and serum deprivation‑induced apoptosis via the Akt/GSK3β and Bcl‑2 signaling pathways.

Authors:  Hongjin Si; Yao Zhang; Yuqing Song; Lili Li
Journal:  Int J Mol Med       Date:  2018-03-05       Impact factor: 4.101

Review 5.  Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy.

Authors:  Ramiro Vázquez; Maria E Riveiro; Caroline Berenguer-Daizé; Anthony O'Kane; Julie Gormley; Olivier Touzelet; Keyvan Rezai; Mohamed Bekradda; L'Houcine Ouafik
Journal:  Front Oncol       Date:  2021-01-06       Impact factor: 6.244

Review 6.  Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Xinyang Liu; Zhichao Wang; Zongwei Chen; Longzi Liu; Lijie Ma; Liangqing Dong; Zhao Zhang; Shu Zhang; Liuxiao Yang; Jieyi Shi; Jia Fan; Xiaoying Wang; Qiang Gao
Journal:  Oncol Res       Date:  2017-09-14       Impact factor: 5.574

7.  Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia.

Authors:  Giorgia Simonetti; Davide Angeli; Elisabetta Petracci; Eugenio Fonzi; Susanna Vedovato; Alessandra Sperotto; Antonella Padella; Martina Ghetti; Anna Ferrari; Valentina Robustelli; Rosa Di Liddo; Maria Teresa Conconi; Cristina Papayannidis; Claudio Cerchione; Michela Rondoni; Annalisa Astolfi; Emanuela Ottaviani; Giovanni Martinelli; Michele Gottardi
Journal:  Front Oncol       Date:  2021-06-02       Impact factor: 6.244

8.  Correlation of adrenomedullin with the erythropoietin receptor and microvessel density in hepatocellular carcinoma.

Authors:  Zhen Qu; Yong Jiang; Ming Xu; Ming Zhu Lu; Bin Zhou; Yitao Ding
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.